Kaya 959 Kaya Biz

Kumba reports a 24% fall in headline earnings

Loading player...
GUEST – Mpumi Zikalala - Kumba CEO
Kumba Iron Ore has reported a 24% fall in headline earnings per share as the company battles weaker commodity prices and logistics challenges.
Kumba, a subsidiary of the Anglo American group, on Tuesday released its results for the six months ended in June 2024 and reported headline earnings per share of R22.27, down from R30.04 in the first half of 2023.
Kumba also cut its interim dividend to R18.77 per share – down 17% from R22.60, although this still represents a payout ratio of 85% of headline earnings.
23 Jul 2024 3PM English South Africa Business News · Investing

Other recent episodes

Family Business to National Player: Anton Gillis on SA’s Hospitality Future

Platinum Hospitality Holdings is set to announce Anton Gillis as its new CEO — marking a major succession moment for one of SA’s leading family‑built hotel groups. Anton shares what the group is seeing on the ground across its national portfolio, where hospitality demand is growing, how operators are navigating…
27 Jul 1PM 15 min

SA Consumers Under Pressure: Retail Signals & MPC Reality

South Africa’s consumer is flashing warning signs — and two retail updates have sharpened the picture. Cashbuild’s weak building materials demand and Mr Price’s shift toward value purchases reveal households under severe pressure. Market analyst The Finance Ghost unpacks how sticky inflation, high interest rates and the MPC’s cautious stance…
27 Jul 12PM 12 min

Why Women’s Financial Empowerment Is an Economic Multiplier

Women’s financial empowerment has the potential to drive economic growth, strengthen households and create lasting generational wealth. Kaya Biz speaks to Alexandra Nortier, Joint Head of Wealth Management at Investec Wealth & Investment International, about why Investec is backing the JSE SheInvests 2026 initiative, the barriers keeping women out of…
23 Jul 1PM 7 min

Affordable Diabetes Care Arrives in SA with Novo Nordisk

Novo Nordisk South Africa GM Sara Norcross explains the launch of the country’s only authorised copy of semaglutide, manufactured using the identical API, process and device as the originator — but at a more affordable price. We unpack what an authorised copy is, why SAHPRA registration matters, how the Acino…
23 Jul 1PM 14 min

SARB holds rates steady in July MPC – What It Means for You

Momentum economist Tshiamo Masike unpacks the SARB’s decision to pause, the upside inflation surprise, and the global factors driving the MPC’s decision. We explore how rising oil prices, geopolitical tensions, and weakening consumer confidence shaped the call — and what households, businesses and markets should expect next. A sharp, data‑driven…
23 Jul 1PM 14 min
All episodes